The purpose of this article is to outline the pharmacodynamics, pharmacology, and evidence for the use of olanzapine in palliative care
2014
Nevertheless, studies on oral doses of olanzapine to healthy individuals and psychiatric patients help to interpret mechanisms of action (see [ 22 , 23 ] for detailed
Aim To evaluate the evidence for olanzapine, given orally or subcutaneously (sc), in the
Given the emerging use of olanzapine as an antiemetic in both CINV and palliative care, it is important to establish the evidence base for its use in the prevention and treatment of nausea and vomiting
Consider pre-emptive use of anti-nauseates in opioid-naive patients
The Syringe Driver Continuous subcutaneous infusions in palliative care
com 2 The syringe drive database available at www
Introduction and Aims
Olanzapine, a newer atypical anti-psychotic with a more favourable side Introduction
Call 1-855-412-2121 (open seven days a week, 8:30 a
However, several drug combinations are usually used to treat emesis
Multiple organizations recommend integrating palliative care into cancer treatment from the time of diagnosis
We report a case of an advanced cancer patient cared